MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment.

Autor: Vicente, André T. S.1 (AUTHOR), Salvador, Jorge A. R.1,2 (AUTHOR) salvador@ci.uc.pt
Zdroj: International Journal of Molecular Sciences. Oct2022, Vol. 23 Issue 19, p11068. 30p.
Databáze: Academic Search Ultimate